Skin Elements (ASX:SKN) R&D Tax Rebate Update

Skin Elements Limited (ASX:SKN) has received a Research & Development Tax Rebate of $1,193,629 resulting from the qualifying R&D expenditure invested in the 2024 financial year. The rebate is a testament to the Company's ongoing dedication to the research and development of its SE Natural Biotechnology.

Executive Commentary on R&D Tax Rebate

We are pleased to announce that Skin Elements Limited has received a Research & Development Tax Rebate of $1,193,629, reflecting our steadfast commitment to advancing our SE Natural Biotechnology. This rebate is a recognition of our continuous efforts in driving innovation and developing plant-based and organic sourced ingredients. It further strengthens our position in delivering natural, sustainable, and globally applicable formulations. We remain focused on leveraging this rebate to further our research and development initiatives. - Peter Malone, Executive Chairman

Summary of Skin Elements R&D Tax Rebate Announcement

Skin Elements Limited (ASX:SKN) has successfully secured a Research & Development Tax Rebate of $1,193,629, underscoring the Company's unwavering dedication to advancing its SE Natural Biotechnology. The rebate is a result of the qualifying R&D expenditure invested in the 2024 financial year. Skin Elements continues to lead in the development of all natural plant-based formulations with global applications, including the SuprCuvr TGA-registered disinfectant, ECO-Nurture plant bio-stimulant, Soléo Organics sunscreen, PapayaActivs skincare products, and the Elizabeth Jane Natural Cosmetics brand. The Company's receipt of the rebate reaffirms its commitment to innovation and sustainability, positioning it for further growth and development in the natural biotechnology sector.